Quantifying the Impact of Expanded Age Group Campaigns for Polio Eradication

Open Access

Peer-reviewed

Research Article

Bradley G. Wagner ,

* E-mail: bwagner@intven.com

Affiliation Institute for Disease Modeling, Bellevue, Washington, United States of America
⨯
Matthew R. Behrend,

Affiliation Institute for Disease Modeling, Bellevue, Washington, United States of America
⨯
Daniel J. Klein,

Affiliation Institute for Disease Modeling, Bellevue, Washington, United States of America
⨯
Alexander M. Upfill-Brown,

Affiliation Institute for Disease Modeling, Bellevue, Washington, United States of America
⨯
Philip A. Eckhoff,

Affiliation Institute for Disease Modeling, Bellevue, Washington, United States of America
⨯
Hao Hu

Affiliation Institute for Disease Modeling, Bellevue, Washington, United States of America
⨯

Reader Comments (0)

Poliomyelitis
Is the Subject Area "Poliomyelitis" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Mucosal immunity
Is the Subject Area "Mucosal immunity" applicable to this article?

Thanks for your feedback.
Age groups
Is the Subject Area "Age groups" applicable to this article?

Thanks for your feedback.
Immunity
Is the Subject Area "Immunity" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Poliovirus
Is the Subject Area "Poliovirus" applicable to this article?

Thanks for your feedback.